Table 1.
Clinical and demographical data of enrolled subjects.
| Patient groups | n | Age range (mean) | Female (n) % | AFB pos. (n) % | Culture pos (n) % | IGRA pos (n) % |
|---|---|---|---|---|---|---|
| Active TB (TB) | 25 | 24–87 (44) | 10 (40) | 19 (76) | 24 (96) | n/d |
| Active TB, pulmonary (TB) | 22 | 26–87 (45) | 8 (36) | 19 (86) | 21 (95) | n/d |
| Active TB, extrapulmonary (TB) | 3 | 24–61 (36) | 2 (67) | 0 (0) | 3 (100) | n/d |
| Latently infected (LTBI) | 20 | 34–77 (61) | 10 (50) | n/d | n/d | 20 (100) |
| Rheumatic diseasesa | 13 | 49–77 (65) | 8 (62) | n/d | n/d | 13 (100) |
| Miscellaneous conditionsb | 7 | 34–64 (56) | 2 (29) | n/d | n/d | 7 (100) |
| Healthy BCG vaccinees (BCG) | 8 | 25–50 (34) | 6 (75) | n/d | n/d | 0 (0) |
n/d, not defined.
aRA, rheumatic arthritis (n = 10); JRA, juvenile rheumatic arthritis (n = 1), vasculitis (n = 1), SPA ankylosing spondylitis (n = 1).
bInfection other than TB (n = 5), COPD (n = 1), weakness of skin sensation (n = 1).